EAM
DTIL icon

Empery Asset Management’s Precision BioSciences DTIL Stock Holding History

Empery Asset Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.1M Sell
776,093
-1,192,786
-61% -$8.39M 7.05% 4
2026
Q1 		$10.8M Sell
1,968,879
-225,756
-10% -$1.04M 13.04% 3
2025
Q4 		$9.13M Buy
+2,194,635
New +$12.5M 8.05% 5

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Empery Asset Management's DTIL Position: Q2 2026 in Review

Empery Asset Management reduced its Precision BioSciences (DTIL) stake by 61% in Q2 2026, selling an estimated $8.39M and leaving 776,093 shares worth $6.1M. The position accounts for 7.05% of the portfolio, ranked #4.

Empery Asset Management first reported a position in DTIL in Q4 2025 and has held it in 3 quarters since. The position peaked at $10.8M in Q1 2026. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Empery Asset Management held 776,093 shares of Precision BioSciences worth $6.1M as of Q2 2026.
  • Empery Asset Management sold 1,192,786 Precision BioSciences shares in Q2 2026, an estimated $8.39M.
  • Precision BioSciences made up 7.05% of Empery Asset Management's portfolio in Q2 2026, its #4 holding.
  • Empery Asset Management first reported a position in Precision BioSciences in Q4 2025 and has held it in 3 quarters since.
  • Empery Asset Management's Precision BioSciences position peaked at $10.8M in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Empery Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.